Top Markets
Coin of the day
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock

Cadrenal Therapeutics, Inc. Common Stock

CVKD
Hisse Senetlerindeki Sıralama #33958
Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise... Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, a novel therapeutic agent that has received orphan drug designation. This treatment is engineered to prevent systemic thromboembolism originating from cardiac issues in patients suffering from both end-stage renal disease and atrial fibrillation. Established in 2022, the firm is headquartered in Ponte Vedra, Florida.
Hisse Fiyatı
$1.83
Son senkronizasyon: 2026-08-14
Piyasa Değeri
$6.53M
Değişim (1 gün)
-1.61%
Değişim (1 yıl)
-85.57%
Ülke
US
Ticaret Cadrenal Therapeutics, Inc. Common Stock (CVKD)

Kategori

Cadrenal Therapeutics, Inc. Common Stock (CVKD) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $1.89 - 2026-08-01

Gün sonu en düşük fiyat: $46.78 - 2023-01-01
Cadrenal Therapeutics, Inc. Common Stock için hisse fiyatı geçmişi: 2023 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) -11.31%
2025 -35.19%
2024 69.00%
2023 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE